Knowable Magazine reports 2025 faced turmoil in U.S. science amid job cuts and budget slashes, yet saw advances in gene ...

PALI-2108 is the first and only PDE4 inhibitor in development targetingthe terminal ileum and colon for treatment of ulcerative colitis (UC) and ...

US team has developed Enzymatic Structural Material, a carbon-negative alternative to concrete that turns CO2 into a ...

Cardiovascular disease remains a leading global cause of death, and we break down its pathology, risk factors, and the ...

For more than 50 years, scientists have sought alternatives to silicon for building molecular electronics. The vision was ...

Scientists at Johns Hopkins Medicine say results of a new study are advancing efforts to exploit a new target for Alzheimer's ...

KELOWNA, BC / ACCESS Newswire / December 30, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, provides the ...

And for patients facing extreme limitations to mobility, or who live vast distances from hospitals and clinics, mobile ...

Experiments conducted in genetically engineered mice reinforce that CSE protein (ordinarily known for producing hydrogen ...

This daily moisturiser is also in the bathroom cabinet of Dr Hanson. He tells us, “Powered by the OS01 peptide, this formula ...

Comprehensive Analysis Examines Liposomal NMN Delivery, Dosage Research Context, Third-Party Verification Standards, and What Distinguishes GenuinePurity's NAD+ Precursor Formulation in an Expanding S ...